SCG2 was a member of the chromogranin/secretogranin family of neuroendocrine secretory proteins, and it might contribute to the neuroendocrine differentiation by promoting the formation of secretory granules and the proliferation of prostate cancer cells (Courel et al., 2014). The gene discussed is SCG2; the disease is prostate cancer.